ASPEN AEROGELS INC(ASPN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,498 of 2,879 stocks
View Consumer Discretionary peers →
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ASPN Stock Analysis & AI Quality Score
AI stock analysis and institutional research for ASPEN AEROGELS INC (ASPN), a Consumer Discretionary sector company. 13F Pro's AI-powered ranking engine scores ASPN at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,498 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (1.1) and profitability (6.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 32.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), ASPEN AEROGELS INC reports quarterly revenue of $37.9M, net income of $-23.7M, an operating margin of -55.0%. Top institutional holders of ASPN by reported 13-F value include KIM,, OAKTOP CAPITAL MANAGEMENT II, L.P., BlackRock,, based on the most recent SEC filings. ASPN trades on the NYSE exchange and files with the SEC under CIK 1145986. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ASPN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ASPEN AEROGELS INC directly from SEC EDGAR. ASPEN AEROGELS INC's 13F Pro composite quality score has ranged between 8 and 72 since 2021, currently 26.6 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$37.9M
Net Income
Q1 2026
$-23.7M
Free Cash Flow
Q1 2026
$32.8M
Operating Margin
Q1 2026
-55.0%
D/E Ratio
Q1 2026
0.40
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+89.6% YoYNet Income
+129.2% YoYOperating Income
+210.8% YoYEPS (Diluted)
+125.8% YoYTotal Assets
+27.3% YoYTotal Debt
Op. Cash Flow
+206.9% YoY| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $452.7M +89.6% | $238.7M +32.4% | $180.4M +48.3% | $121.6M +21.3% | $100.3M -28.1% | $139.4M |
| Net Income | $13.4M +129.2% | $-45.8M +44.6% | $-82.7M -123.0% | $-37.1M -70.1% | $-21.8M -49.7% | $-14.6M |
| Operating Income | $54.5M +210.8% | $-49.2M +37.9% | $-79.2M -95.2% | $-40.6M -88.2% | $-21.6M -52.3% | $-14.2M |
| EPS (Diluted) | $0.17 +125.8% | $-0.66 +68.6% | $-2.10 -72.1% | $-1.22 -47.0% | $-0.83 | — |
| Total Assets | $895.1M +27.3% | $703.0M +9.3% | $643.4M +251.7% | $183.0M +87.8% | $97.4M -5.9% | $103.5M |
| Total Debt | $114.7M | — | — | — | $5.3M | — |
| Operating Cash Flow | $45.5M +206.9% | $-42.6M +54.9% | $-94.4M -406.8% | $-18.6M -87.7% | $-9.9M -841.6% | $-1.1M |
Get alerted when ASPN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for ASPEN AEROGELS INC including:
Top Institutional Holders of ASPN
KIM, LLC
$42.0M12,280,426 shOAKTOP CAPITAL MANAGEMENT II, L.P.
$17.7M5,168,674 shBlackRock, Inc.
$16.2M4,743,076 shNEEDHAM INVESTMENT MANAGEMENT LLC
$15.5M4,518,775 shVANGUARD CAPITAL MANAGEMENT LLC
$11.8M3,436,156 shGEORGE KAISER FAMILY FOUNDATION
$10.8M3,167,322 shSTATE STREET CORP
$7.9M2,320,727 shInvesco Ltd.
$7.9M2,298,183 shGAGNON SECURITIES LLC
$6.4M1,861,851 shRICE HALL JAMES & ASSOCIATES, LLC
$5.3M1,552,628 sh
| Fund | Value | Shares |
|---|---|---|
| KIM, LLC | $42.0M | 12,280,426 |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | $17.7M | 5,168,674 |
| BlackRock, Inc. | $16.2M | 4,743,076 |
| NEEDHAM INVESTMENT MANAGEMENT LLC | $15.5M | 4,518,775 |
| VANGUARD CAPITAL MANAGEMENT LLC | $11.8M | 3,436,156 |
| GEORGE KAISER FAMILY FOUNDATION | $10.8M | 3,167,322 |
| STATE STREET CORP | $7.9M | 2,320,727 |
| Invesco Ltd. | $7.9M | 2,298,183 |
| GAGNON SECURITIES LLC | $6.4M | 1,861,851 |
| RICE HALL JAMES & ASSOCIATES, LLC | $5.3M | 1,552,628 |
More Consumer Discretionary Companies
View all Consumer Discretionary →Put ASPN on your watchlist
Track score changes the day ASPEN AEROGELS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ASPN a good stock to buy?
13F Pro's AI-powered analysis of ASPEN AEROGELS INC (ASPN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Discretionary sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ASPN are available on the ASPN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ASPN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ASPN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ASPEN AEROGELS INC's investment landscape.